Live Breaking Biotech News and Articles

Biotech News Journal

Subscribe to Biotech News Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Biotech News Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Biotech Authors: Greg Wind

Related Topics: CEOs in Technology, Oracle Journal, Biotech News Journal, Pharmaceutical News, CIO/CTO Update

News Feed Item

Dotmatics Licenses Their Integrated Suite of Solutions for Pre-Clinical Research Informatics to Basilea

BISHOPS STORTFORD, UNITED KINGDOM -- (Marketwire) -- 05/08/12 -- Dotmatics Ltd, a leading provider of informatics services to the pharmaceutical and biotechnology industries, today announced that Basilea Pharmaceutica International Ltd have licensed and globally deployed Dotmatics' entire suite of scientific informatics solutions for pre-clinical research data management.

The Dotmatics platform provides for registering, analyzing and managing scientific data, an electronic laboratory notebook for chemistry and biology experiments, the ability to query and report research data, and to visualize with chemical intelligence.

Basilea CSO, Laurenz Kellenberger, PhD, states, "With the integrated Dotmatics platform tailored to Basilea's specific needs, we are further enhancing the way we globally consolidate and learn from biological and chemical research data. We look forward to continue working with Dotmatics to efficiently address our future informatics requirements in chemistry and biology."

"We are really excited to have this opportunity to provide a suite of tools for global deployment in Basilea's research group and to be able to collaborate with them," said Stephen Gallagher, PHD and CEO of Dotmatics. "We are committed to delivering high quality solutions and services to ensure that the informatics requirements of Basilea's R & D are fulfilled" he added.

About Dotmatics

Dotmatics has rapidly emerged as a preferred informatics supplier to many of the top global pharmaceutical, biotechnology, and academic organisations. Dotmatics is a scientific software company deploying web-based knowledge solutions that dramatically improve the way scientific data is queried, managed and shared within companies. Dotmatics has significant expertise in chem- and bioinformatics techniques including chemical databases, SAR analysis, data management and data visualization. A privately owned company, Dotmatics was founded in 2005 and has its head office based south of Cambridge, UK.

Solution Highlights:

Browser - Web-based tool for querying, browsing and visualizing biological databases such as IDBS' ActivityBase(TM) and any chemical database.

Vortex - World-class visualization and analytics platform for scientific and non-scientific data.

D40 - Chemistry enabling MS Office.

Bioregister - Web-based tool for registering Biological entities.

Gateway - Securely enables research teams to share information internally and with external partners.

Pinpoint - Powerful Oracle chemical cartridge for querying and integrating chemical databases(i). Pinpoint represents world-class indexing and search performance at a cost-effective price.

Register - Flexible and scalable chemical registration system.

Nucleus - Map and import biological and non-biological data files into an Oracle database.

Studies - The new standard in screening data management.

Studies Notebook - Web-based ELN for all disciplines.

(i)Pinpoint is developed in collaboration with Astex Therapeutics Ltd

About Basilea

Basilea Pharmaceutica Ltd. is a listed (SIX:BSLN) Swiss biopharmaceutical company focused on research, development and commercialization of drugs that address the medical challenge of rising resistance and non-response to current treatment options in the hospital and specialty care setting in the areas of bacterial and fungal infections, oncology and skin diseases.

Contacts:
Enquiries:
Dotmatics Limited
+44(0)1279 654 123
+44(0)1279 653 088 (FAX)
[email protected]
www.dotmatics.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.